Which of the Hepatitis B Virus serological marker indicates the first evidence of Hepatitis B infection?
**Core Concept**
Hepatitis B Virus (HBV) infection is a major public health concern worldwide, causing significant morbidity and mortality. The serological markers of HBV infection are crucial for diagnosis, monitoring, and treatment. Understanding the different markers helps in identifying the stage of infection, viral replication, and potential transmission.
**Why the Correct Answer is Right**
HBsAg (Hepatitis B surface antigen) is the first serological marker to appear in the serum after HBV infection, indicating the initial phase of the infection. It is a protein on the surface of the virus that is responsible for its attachment to hepatocytes. The presence of HBsAg in the serum indicates that the individual is infectious and has a high viral load. This marker is the first evidence of HBV infection and is used as a screening tool for blood banks and donation centers to prevent transmission.
**Why Each Wrong Option is Incorrect**
**Option A:** Anti-HBs (Antibody to Hepatitis B surface antigen) is a marker of immunity to HBV, either due to vaccination or past infection. It appears after HBsAg has cleared from the serum and is not the first evidence of infection.
**Option B:** Anti-HBc (Antibody to Hepatitis B core antigen) is a marker of current or past HBV infection. It appears after HBsAg has cleared from the serum and indicates that the individual has been infected with HBV. However, it does not indicate the first evidence of infection.
**Option C:** HBeAg (Hepatitis B e-antigen) is a marker of viral replication and infectivity. It appears in the serum when HBV is actively replicating and the individual has a high viral load. However, it is not the first evidence of HBV infection.
**Clinical Pearl / High-Yield Fact**
HBsAg is the most sensitive and specific marker for HBV infection, but it has a short window of detection (2-4 weeks). After this period, the individual may test negative, but still be infectious. This is known as the "window period" and highlights the importance of repeated testing in high-risk individuals.
**Correct Answer Line**
✓ Correct Answer: D. HBsAg